These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 15234240

  • 1. Splice variants as cancer biomarkers.
    Brinkman BM.
    Clin Biochem; 2004 Jul; 37(7):584-94. PubMed ID: 15234240
    [Abstract] [Full Text] [Related]

  • 2. Alterations of pre-mRNA splicing in cancer.
    Kalnina Z, Zayakin P, Silina K, Linē A.
    Genes Chromosomes Cancer; 2005 Apr; 42(4):342-57. PubMed ID: 15648050
    [Abstract] [Full Text] [Related]

  • 3. Alternative splicing in cancer: noise, functional, or systematic?
    Skotheim RI, Nees M.
    Int J Biochem Cell Biol; 2007 Apr; 39(7-8):1432-49. PubMed ID: 17416541
    [Abstract] [Full Text] [Related]

  • 4. Aberrant and alternative splicing in cancer.
    Venables JP.
    Cancer Res; 2004 Nov 01; 64(21):7647-54. PubMed ID: 15520162
    [Abstract] [Full Text] [Related]

  • 5. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T, Shkreta L, Chabot B.
    Bull Cancer; 2006 Sep 01; 93(9):909-19. PubMed ID: 16980234
    [Abstract] [Full Text] [Related]

  • 6. The connection between splicing and cancer.
    Srebrow A, Kornblihtt AR.
    J Cell Sci; 2006 Jul 01; 119(Pt 13):2635-41. PubMed ID: 16787944
    [Abstract] [Full Text] [Related]

  • 7. [A progress toward research on alternative splicing of genes in tumor cells].
    Zhou ZR, Sun KL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr 01; 23(2):177-80. PubMed ID: 16604490
    [Abstract] [Full Text] [Related]

  • 8. [Disturbances of alternative splicing in cancer].
    Wiszomirska H, Piekiełko-Witkowska A, Nauman A.
    Postepy Biochem; 2011 Apr 01; 57(3):257-65. PubMed ID: 22235651
    [Abstract] [Full Text] [Related]

  • 9. Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles.
    Liao P, Yong TF, Liang MC, Yue DT, Soong TW.
    Cardiovasc Res; 2005 Nov 01; 68(2):197-203. PubMed ID: 16051206
    [Abstract] [Full Text] [Related]

  • 10. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer.
    Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH, Lee MP.
    Cancer Res; 2003 Feb 01; 63(3):655-7. PubMed ID: 12566310
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS, Shen CY, Wang HW, Wu PE, Cheng CW.
    Clin Chim Acta; 2007 Sep 01; 384(1-2):69-74. PubMed ID: 17651715
    [Abstract] [Full Text] [Related]

  • 12. Genome-wide detection of testis- and testicular cancer-specific alternative splicing.
    He C, Zuo Z, Chen H, Zhang L, Zhou F, Cheng H, Zhou R.
    Carcinogenesis; 2007 Dec 01; 28(12):2484-90. PubMed ID: 17724370
    [Abstract] [Full Text] [Related]

  • 13. Candidates for tumor-specific alternative splicing.
    Okumura M, Kondo S, Ogata M, Kanemoto S, Murakami T, Yanagida K, Saito A, Imaizumi K.
    Biochem Biophys Res Commun; 2005 Aug 19; 334(1):23-9. PubMed ID: 16018876
    [Abstract] [Full Text] [Related]

  • 14. Splicing factors are differentially expressed in tumors.
    Kirschbaum-Slager N, Lopes GM, Galante PA, Riggins GJ, de Souza SJ.
    Genet Mol Res; 2004 Dec 30; 3(4):512-20. PubMed ID: 15688317
    [Abstract] [Full Text] [Related]

  • 15. Cloning of potassium channel splice variants from tissues and cells.
    Chen L, Shipston MJ.
    Methods Mol Biol; 2008 Dec 30; 491():35-60. PubMed ID: 18998082
    [Abstract] [Full Text] [Related]

  • 16. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ, Luk JM, Leung PP, Wong BW, Stanbridge EJ, Fan ST.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [Abstract] [Full Text] [Related]

  • 17. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R, An SJ, Chen ZH, Zhang GC, Zhu JQ, Nie Q, Xie Z, Guo AL, Mok TS, Wu YL.
    Hum Pathol; 2008 Dec 15; 39(12):1792-801. PubMed ID: 18715616
    [Abstract] [Full Text] [Related]

  • 18. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
    Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, Davies C, Williams A, Turpaz Y.
    BMC Genomics; 2006 Dec 27; 7():325. PubMed ID: 17192196
    [Abstract] [Full Text] [Related]

  • 19. Opportunities and methods for studying alternative splicing in cancer with RNA-Seq.
    Feng H, Qin Z, Zhang X.
    Cancer Lett; 2013 Nov 01; 340(2):179-91. PubMed ID: 23196057
    [Abstract] [Full Text] [Related]

  • 20. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays.
    Yoshida R, Numata K, Imoto S, Nagasaki M, Doi A, Ueno K, Miyano S.
    Genome Inform; 2006 Nov 01; 17(1):88-99. PubMed ID: 17503359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.